These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Synthetic cannabinoid use among college students. Mathews EM; Jeffries E; Hsieh C; Jones G; Buckner JD Addict Behav; 2019 Jun; 93():219-224. PubMed ID: 30772774 [TBL] [Abstract][Full Text] [Related]
83. Suicide attempt with a mix of synthetic cannabinoids and synthetic cathinones: Case report of non-fatal intoxication with AB-CHMINACA, AB-FUBINACA, alpha-PHP, alpha-PVP and 4-CMC. Klavž J; Gorenjak M; Marinšek M Forensic Sci Int; 2016 Aug; 265():121-4. PubMed ID: 26890319 [TBL] [Abstract][Full Text] [Related]
84. Medical needs of emergency department patients presenting with acute alcohol and drug intoxication. Stang JL; DeVries PA; Klein LR; Cole JB; Martel M; Reing ML; Raiter AM; Driver BE Am J Emerg Med; 2021 Apr; 42():38-42. PubMed ID: 33440329 [TBL] [Abstract][Full Text] [Related]
85. Modulation of human T-type calcium channels by synthetic cannabinoid receptor agonists in vitro. Bladen C; Mirlohi S; Santiago M; Longworth M; Kassiou M; Banister S; Connor M Neuropharmacology; 2021 Apr; 187():108478. PubMed ID: 33600843 [TBL] [Abstract][Full Text] [Related]
86. Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists: a report from the United Kingdom National Poisons Information Service. Waugh J; Najafi J; Hawkins L; Hill SL; Eddleston M; Vale JA; Thompson JP; Thomas SH Clin Toxicol (Phila); 2016 Jul; 54(6):512-8. PubMed ID: 27091041 [TBL] [Abstract][Full Text] [Related]
87. Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes. Carlier J; Diao X; Sempio C; Huestis MA AAPS J; 2017 Mar; 19(2):568-577. PubMed ID: 28070717 [TBL] [Abstract][Full Text] [Related]
88. Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies. Canazza I; Ossato A; Trapella C; Fantinati A; De Luca MA; Margiani G; Vincenzi F; Rimondo C; Di Rosa F; Gregori A; Varani K; Borea PA; Serpelloni G; Marti M Psychopharmacology (Berl); 2016 Oct; 233(21-22):3685-3709. PubMed ID: 27527584 [TBL] [Abstract][Full Text] [Related]
89. Use of synthetic cannabinoids in patients with psychotic disorders: case series. Celofiga A; Koprivsek J; Klavz J J Dual Diagn; 2014; 10(3):168-73. PubMed ID: 25392292 [TBL] [Abstract][Full Text] [Related]
90. Synthetic cannabinoid AM2201 induces seizures: Involvement of cannabinoid CB Funada M; Takebayashi-Ohsawa M Toxicol Appl Pharmacol; 2018 Jan; 338():1-8. PubMed ID: 29042214 [TBL] [Abstract][Full Text] [Related]
91. Synthetic cannabinoid use among patients in residential substance use disorder treatment: prevalence, motives, and correlates. Bonar EE; Ashrafioun L; Ilgen MA Drug Alcohol Depend; 2014 Oct; 143():268-71. PubMed ID: 25096272 [TBL] [Abstract][Full Text] [Related]
92. The characteristics and outcomes of toxin-induced massive rhabdomyolysis. Waldman W; Sein Anand J; Kabata P Int J Occup Med Environ Health; 2020 Sep; 33(5):661-673. PubMed ID: 32716014 [TBL] [Abstract][Full Text] [Related]
97. Unintentional Exposure of an Infant to Synthetic Cannabinoid (Bonzai) Related to the Parent's Use. Dinleyici M; Kiral E; Sahin S; Carman KB Pediatr Emerg Care; 2020 Jun; 36(6):e355-e357. PubMed ID: 29698342 [TBL] [Abstract][Full Text] [Related]
98. Gastrointestinal manifestations of synthetic cannabinoids: a retrospective cohort study. Hakimian D; Benson AA; Khoury T; Massarwa M; Israel S; Salameh S; Gershinsky Y; Shapira B; Muszkat M BMC Gastroenterol; 2021 Jul; 21(1):274. PubMed ID: 34229620 [TBL] [Abstract][Full Text] [Related]
99. The next generation of synthetic cannabinoids: Detection, activity, and potential toxicity of pent-4en and but-3en analogues including MDMB-4en-PINACA. Krotulski AJ; Cannaert A; Stove C; Logan BK Drug Test Anal; 2021 Feb; 13(2):427-438. PubMed ID: 32997377 [TBL] [Abstract][Full Text] [Related]
100. A case of intoxication with a mixture of synthetic cannabinoids EAM-2201, AB-PINACA and AB-FUBINACA, and a synthetic cathinone α-PVP. Yamagishi I; Minakata K; Nozawa H; Hasegawa K; Suzuki M; Kitamoto T; Suzuki O; Watanabe K Leg Med (Tokyo); 2018 Nov; 35():44-49. PubMed ID: 30268690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]